Covid-19: Zimbabwe to get 200 000 vaccine doses from China's Sinopharm for free

0:00
play article
Subscribers can listen to this article
A volunteer receives an injection for a potential vaccine.
A volunteer receives an injection for a potential vaccine.
Felix Dlangamandla/Beeld/Gallo Images via Getty Im

 Zimbabwe will receive 200 000 free doses of China's Sinopharm Covid-19 vaccine, President Emmerson Mnangagwa said on Thursday, after China and Russia offered shots against the coronavirus to the impoverished southern African nation.

Mnangagwa, in a nationally televised address, also said there were plans to vaccinate at least 60% of the population using government and private sector funding.

The coronavirus pandemic has increased rapidly in Zimbabwe over the past few weeks, with about 70% of its known 33 964 infections and more than two thirds of the 1 269 deaths recorded since the beginning of January.

The Sinopharm vaccine is approved in China for general public use and is also being administered in a number of other countries. "This kind gesture attests to the fact that China is indeed a true friend of Zimbabwe," Mnangagwa said.

Investor

China is a major investor in Zimbabwe especially in diamond mining and the energy sector, where it is building power stations, and is providing loans after Western lenders pulled out following more than two decades of Zimbabwean arrears.

Chinese Ambassador Guo Shaochun said on Tuesday Zimbabwe was one of the first 14 countries to receive vaccine aid from Beijing.

Mnangagwa said his government had finalised a vaccine deployment strategy that would see at least 9 million people - 60% of the population - being inoculated.

"First phase of inoculation will see frontline workers, the elderly and those with underlying medical conditions being prioritised," he said, giving no further detail.

A finance ministry official said last week Zimbabwe had set aside $100 million to procure Covid-19 vaccines.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Would you choose to continue working from home after the coronavirus lockdown if given the option?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, it's much better for me
40% - 6594 votes
No ways! I can't wait to get back to the office
12% - 1936 votes
A mixture of both would suit me best
48% - 7934 votes
Vote
USD/ZAR
14.61
(0.0)
GBP/ZAR
20.02
(0.0)
EUR/ZAR
17.37
(0.0)
AUD/ZAR
11.13
(0.0)
JPY/ZAR
0.13
(0.0)
Gold
1,743.98
(0.0)
Silver
25.25
(0.0)
Platinum
1,204.50
(0.0)
Brent Crude
62.95
(-0.4)
Palladium
2,641.93
(0.0)
All Share
67,191
(+0.2)
Top 40
61,459
(+0.3)
Financial 15
12,123
(+0.8)
Industrial 25
87,544
(+0.1)
Resource 10
68,608
(+0.2)
All JSE data delayed by at least 15 minutes Iress logo